Clinical Trials Browser

Enrolling by invitation × INDUSTRY × TNBC × Clear all

NCT07376629 2026-01-29

A Study of HB0025 Plus Nab-paclitaxel as First Line Therapy for TNBC

Phase 2 Enrolling by invitation

TNBC